BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galvez JM, Restrepo CM, Contreras NC, Alvarado C, Calderón-Ospina CA, Peña N, Cifuentes RA, Duarte D, Laissue P, Fonseca DJ. Creating and validating a warfarin pharmacogenetic dosing algorithm for Colombian patients. Pharmgenomics Pers Med 2018;11:169-78. [PMID: 30410385 DOI: 10.2147/PGPM.S170515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Calderon-Ospina CA, Galvez JM, López-Cabra C, Morales N, Restrepo CM, Rodríguez J, Aristizábal-Gutiérrez FA, Velez-van-Meerbeke A, Laissue P, Fonseca-Mendoza DJ. Possible Genetic Determinants of Response to Phenytoin in a Group of Colombian Patients With Epilepsy. Front Pharmacol 2020;11:555. [PMID: 32457604 DOI: 10.3389/fphar.2020.00555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Valencia Ayala E, Chevarría Arriaga M, Coelho EB, Sandoval JS, Granara AS. Metabolizer phenotype prediction in different Peruvian ethnic groups through CYP2C9 polymorphisms. Drug Metab Pers Ther 2021. [PMID: 33735946 DOI: 10.1515/dmpt-2020-0146] [Reference Citation Analysis]
3 Asiimwe IG, Pirmohamed M. Ethnic Diversity and Warfarin Pharmacogenomics. Front Pharmacol 2022;13:866058. [PMID: 35444556 DOI: 10.3389/fphar.2022.866058] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tajik F, Wang M, Zhang X, Han J. Evaluation of the impact of body mass index on venous thromboembolism risk factors. PLoS One 2020;15:e0235007. [PMID: 32645000 DOI: 10.1371/journal.pone.0235007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Roco A, Nieto E, Suárez M, Rojo M, Bertoglia MP, Verón G, Tamayo F, Arredondo A, Cruz D, Muñoz J, Bravo G, Salas P, Mejías F, Godoy G, Véliz P, Quiñones LA. A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study. Front Pharmacol 2020;11:325. [PMID: 32327994 DOI: 10.3389/fphar.2020.00325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
6 Rojo M, Roco AM, Suarez M, Lavanderos MA, Verón G, Bertoglia MP, Arredondo A, Nieto E, Rubilar JC, Tamayo F, Cruz D, Muñoz J, Bravo G, Salas P, Mejías F, Véliz P, Godoy G, Varela NM, Llull G, Quiñones LA. Functionally Significant Coumarin-Related Variant Alleles and Time to Therapeutic Range in Chilean Cardiovascular Patients. Clin Appl Thromb Hemost 2020;26:1076029620909154. [PMID: 32228310 DOI: 10.1177/1076029620909154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fonseca DJ, Morel A, Llinás-Caballero K, Bolívar-Salazar D, Laissue P. Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype. Pharmgenomics Pers Med 2021;14:287-99. [PMID: 33688237 DOI: 10.2147/PGPM.S289869] [Reference Citation Analysis]
8 Silgado-guzmán DF, Angulo-aguado M, Morel A, Niño-orrego MJ, Ruiz-torres D, Contreras Bravo NC, Restrepo CM, Ortega-recalde O, Fonseca-mendoza DJ. Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing. Front Pharmacol 2022;13:931531. [DOI: 10.3389/fphar.2022.931531] [Reference Citation Analysis]
9 Steiner HE, Giles JB, Patterson HK, Feng J, El Rouby N, Claudio K, Marcatto LR, Tavares LC, Galvez JM, Calderon-Ospina CA, Sun X, Hutz MH, Scott SA, Cavallari LH, Fonseca-Mendoza DJ, Duconge J, Botton MR, Santos PCJL, Karnes JH. Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans. Front Pharmacol 2021;12:749786. [PMID: 34776967 DOI: 10.3389/fphar.2021.749786] [Reference Citation Analysis]